Status:
COMPLETED
Long-term Study of SYR-472
Lead Sponsor:
Takeda
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
To evaluate the safety and efficacy of long-term treatment with SYR-472 in diabetic patients.
Eligibility Criteria
Inclusion
- The participant is an outpatient.
- The participant signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.
- Diabetes Mellitus
Exclusion
- The participant has any serious cardiac disease, serious cerebrovascular disorder, or any serious pancreatic or hematological disease.
- The participant is considered ineligible for the study for any other reason by the investigator or subinvestigator.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
680 Patients enrolled
Trial Details
Trial ID
NCT01431807
Start Date
September 1 2011
End Date
June 1 2013
Last Update
December 14 2023
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Akita, Akita, Japan
2
Kisarazu-shi, Chiba, Japan
3
Fukuoka, Fukuoka, Japan
4
Munakata-shi, Fukuoka, Japan